Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2582-8185 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Inclisirán as an alternative treatment for Hypercholesterolemia

Breadcrumb

  • Home
  • Inclisirán as an alternative treatment for Hypercholesterolemia

Jorge Andrés Ojeda Villota 1, *, Javier Alfredo Pérez Martínez 2, Luis Alberto Burgos de Moya 3, Rodrigo Alfonso Chavez Vega 4, Roxana Rivera Valencia 5, Laura Melissa Medina Medina 6, María Paula González Rodríguez 7 and Ingrith Tatiana Poveda Castillo 8

1 Internist, Universidad Metropolitana, Barranquilla.
2 Internist, Universidad Libre, Barranquilla.
3 Internist, Universidad Simón Bolívar, Barranquilla 0000-0001-7933-6436.
4 General Physician, Universidad Del Sinú Cartagena.
5 General Physician, Universidad de Carabobo, Venezuela.
6 General Physician, Universidad Industrial de Santander, Bucaramanga.
7 General Physician, Universidad Simón Bolívar.
8 General Physician, Fundación Universitaria Juan N Corpas.
 
Research Article
World Journal of Advanced Research and Reviews, 2021, 12(03), 517–521
Article DOI: 10.30574/wjarr.2021.12.3.0694
DOI url: https://doi.org/10.30574/wjarr.2021.12.3.0694
 
Received on 09 November 2021; revised on 13 December 2021; accepted on 15 December 2021
 
Hypercholesterolemia (CH) is defined as the elevation of serum cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, which is considered to be one of the most relevant risk factors for triggering cardiovascular disease, for This is vitally important to start treatment, there are several highly useful pharmacological groups for lipid-lowering therapy, among them we highlight the PCSK9 inhibitors, among the molecules that are part of this group we find inclisirán, this being a structure that promises a lot in regarding the management of hypercholesterolemia.
 
Include; Treatment; Hypercholesterolemia; LDL elevation; PCSK9 inhibitors
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2021-0694.pdf

Preview Article PDF

Jorge Andrés Ojeda Villota, Javier Alfredo Pérez Martínez, Luis Alberto Burgos de Moya, Rodrigo Alfonso Chavez Vega, Roxana Rivera Valencia, Laura Melissa Medina Medina, María Paula González Rodríguez and Ingrith Tatiana Poveda Castill. Inclisirán as an alternative treatment for Hypercholesterolemia. World Journal of Advanced Research and Reviews, 2021, 12(3), 517-521. Article DOI: https://doi.org/10.30574/wjarr.2021.12.3.0694

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 International Journal of Science and Research Archive - All rights reserved

Developed & Designed by VS Infosolution